We found that more MDSCs infiltrated IL-6 high-expressing cancer tissues, and that tumor-derived IL-6 displayed a strong positive correlation with the number of infiltrating MDSCs in situ at both the mRNA and protein levels. The gene discussed is IL6; the disease is cancer.